Cambridge Investment Research Advisors
MDLN

Cambridge Investment Research Advisors’s Medline Inc MDLN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Sell
6,152
-3,004
-33% -$121K ﹤0.01% 3635
2026
Q1 		$407K Buy
+9,156
New +$404K ﹤0.01% 2995

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors's MDLN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Medline Inc (MDLN) stake by 33% in Q2 2026, selling an estimated $121K and leaving 6,152 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #3635.

Cambridge Investment Research Advisors first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $407K in Q1 2026. 232 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,152 shares of Medline Inc worth $243K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 3,004 Medline Inc shares in Q2 2026, an estimated $121K.
  • Medline Inc made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3635 holding.
  • Cambridge Investment Research Advisors first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • Cambridge Investment Research Advisors's Medline Inc position peaked at $407K in Q1 2026.
  • 232 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.